Anti-inflammatory Medication of Cataract Surgery in Pseudoexfoliation Syndrome – NSAID Is Needed. (2nd July 2020)
- Record Type:
- Journal Article
- Title:
- Anti-inflammatory Medication of Cataract Surgery in Pseudoexfoliation Syndrome – NSAID Is Needed. (2nd July 2020)
- Main Title:
- Anti-inflammatory Medication of Cataract Surgery in Pseudoexfoliation Syndrome – NSAID Is Needed
- Authors:
- Ilveskoski, Lotta
Taipale, Claudia
Tuuminen, Raimo - Abstract:
- ABSTRACT: Background: To optimize the anti-inflammatory treatment of cataract surgery in pseudoexfoliation syndrome (PXF) eyes. Methods: A prospective randomized double-masked trial. Sixty eyes of 60 patients with PXF undergoing routine cataract surgery were randomized for potent topical postoperative anti-inflammatory medication either with prednisolone acetate (10mg/ml), nepafenac (1mg/ml) or their combination. Clinical outcome parameters were recorded at 28 days and 3 months. Recovery from surgery was recorded by a structured home questionnaire. Results: Patient age and gender distribution, and all baseline ophthalmic and surgical parameters were comparable between the study groups. At 28 days, change in central subfield macular thickness was +11.4 ± 11.9 µm in prednisolone acetate group compared to +1.7 ± 16.8 µm in nepafenac ( P = .017), and −0.3 ± 8.7 µm in combination therapy ( P = .010) groups. At 3 months, the values were +11.8 ± 18.1 µm, +1.8 ± 17.5 µm ( P = .055), and −1.3 ± 6.4 µm ( P = .055), respectively. Pseudophakic cystoid macular edema (PCME) was reported in two eyes, both with prednisolone acetate monotherapy. After surgery, conjunctival injection lasted 6.5 ± 5.0 days and irritation of the eye 9.5 ± 8.5 days in prednisolone acetate group compared with nepafenac (2.6 ± 2.2 days; P = .037 and 4.3 ± 5.2 days; P = NS, respectively) and combination therapy (3.3 ± 1.9 days; P = NS and 3.0 ± 4.0 days; P = .025, respectively). Conclusions: Routine cataractABSTRACT: Background: To optimize the anti-inflammatory treatment of cataract surgery in pseudoexfoliation syndrome (PXF) eyes. Methods: A prospective randomized double-masked trial. Sixty eyes of 60 patients with PXF undergoing routine cataract surgery were randomized for potent topical postoperative anti-inflammatory medication either with prednisolone acetate (10mg/ml), nepafenac (1mg/ml) or their combination. Clinical outcome parameters were recorded at 28 days and 3 months. Recovery from surgery was recorded by a structured home questionnaire. Results: Patient age and gender distribution, and all baseline ophthalmic and surgical parameters were comparable between the study groups. At 28 days, change in central subfield macular thickness was +11.4 ± 11.9 µm in prednisolone acetate group compared to +1.7 ± 16.8 µm in nepafenac ( P = .017), and −0.3 ± 8.7 µm in combination therapy ( P = .010) groups. At 3 months, the values were +11.8 ± 18.1 µm, +1.8 ± 17.5 µm ( P = .055), and −1.3 ± 6.4 µm ( P = .055), respectively. Pseudophakic cystoid macular edema (PCME) was reported in two eyes, both with prednisolone acetate monotherapy. After surgery, conjunctival injection lasted 6.5 ± 5.0 days and irritation of the eye 9.5 ± 8.5 days in prednisolone acetate group compared with nepafenac (2.6 ± 2.2 days; P = .037 and 4.3 ± 5.2 days; P = NS, respectively) and combination therapy (3.3 ± 1.9 days; P = NS and 3.0 ± 4.0 days; P = .025, respectively). Conclusions: Routine cataract surgery of PXF eyes with nonsteroidal anti-inflammatory drugs (NSAID) alone, or in combination with steroids resulted in faster recovery from surgery and avoidance of PCME compared to steroids alone. Abbreviations: BAB: blood–aqueous barrier; CDVA: corrected distance visual acuity; CDE: cumulative dissipated energy; CSMT: central subfield macular thickness; HRQoL: Health-related quality of life; IOP: intraocular pressure; logMAR: log of the minimum angle of resolution; NSAID: nonsteroidal anti-inflammatory drug; PCME: pseudophakic cystoid macular edema; PXF: pseudoexfoliation syndrome; OCT: optical coherence tomography; t.i.d.: three times a day; VA: visual acuity … (more)
- Is Part Of:
- Current eye research. Volume 45:Number 7(2020)
- Journal:
- Current eye research
- Issue:
- Volume 45:Number 7(2020)
- Issue Display:
- Volume 45, Issue 7 (2020)
- Year:
- 2020
- Volume:
- 45
- Issue:
- 7
- Issue Sort Value:
- 2020-0045-0007-0000
- Page Start:
- 814
- Page End:
- 819
- Publication Date:
- 2020-07-02
- Subjects:
- Cataract surgery -- pseudoexfoliation syndrome -- NSAID -- pseudophakic cystoid macular edema
Ophthalmology -- Periodicals
Eye -- Diseases -- Periodicals
Ophthalmology -- Periodicals
573.88 - Journal URLs:
- http://informahealthcare.com/journal/cey ↗
http://www.tandfonline.com/toc/icey20/current ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/02713683.2019.1701686 ↗
- Languages:
- English
- ISSNs:
- 0271-3683
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3496.570000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13643.xml